Results 201 to 210 of about 53,392 (269)

Uncovering hidden risk: The role of social history in identifying possible latent tuberculosis infection in primary care. [PDF]

J Family Med Prim Care
Rahman M, Ferreiro FL.
europepmc   +1 more source

Cost-effectiveness of latent tuberculosis infection testing and preventive treatment among TB contacts in China: a Markov model. [PDF]

BMC Health Serv Res
Li J, Wen Y, Ge F, Qiu Y, Xu C.
europepmc   +1 more source

Integrated metabolomic and transcriptomic analysis reveals novel plasma biomarkers and metabolic pathway dysregulation in latent tuberculosis infection. [PDF]

Microbiol Spectr
Liu D, Feng Z, Meng X, Li Y, Zeng Y, Li Y, Yan F, Wang Y.   +7 more
europepmc   +1 more source

Effect of PPD inoculation on serum cytokine profiles in latent tuberculosis infection populations. [PDF]

Front Cell Infect Microbiol
Chang W, Sun D, Zhang Y, Ji S, Wang S, Wang W, Ma X, Zheng D, Su R, Zhu Y, Shi J, Diao L.   +11 more
europepmc   +1 more source

Comparative Diagnostic Performance of TST and IGRAs in the Diagnosis of Latent Tuberculosis Infection: A Systematic Review and Diagnostic Meta-Analysis. [PDF]

Diagnostics (Basel)
Sriram S, Abualfaraj T, Alsharif MA, Zalat M, Alawfi SM, Fadlalmola HA, Albadrani M.   +6 more
europepmc   +1 more source

Pan-Immune-Inflammatory value and risk of latent tuberculosis infection. [PDF]

Sci Rep
Ye X, Kang X, Zhang H, Wang W.
europepmc   +1 more source

Identification of risk factors for latent tuberculosis infection in Xinjiang using machine learning. [PDF]

BMC Public Health
Wang Y, Luo Z, Wen X, Yuan L, Wu Y, Kamili M, Xiang Y.   +6 more
europepmc   +1 more source

Comparison of Tuberculosis Exposure Frequency and Latent Tuberculosis Infection Rates Among Healthcare Workers by Occupational Classification. [PDF]

J Clin Med
Cheon S, Kim SH, Park JH, Lee YJ, Shin JM, Ryu JS, Hong NS, Cho J, Jun CH, Wi YM.   +9 more
europepmc   +1 more source

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion. [PDF]

Transpl Infect Dis
Simkins J, Viotti JB, Natori Y, Anjan S, Mattiazzi A, Ortigosa-Goggins M, Guerra G, Roth D, Kupin W, Pagan JA, Cabeza F, Ciancio G, Morsi M, Morris MI.   +13 more
europepmc   +1 more source